MAM
Sonali Iyer joins SABTNL as V-P north, west India ad sales
MUMBAI: Sonali Iyer will be joining Sri Adhikari Brothers Television Networks (SABTNL) as ad sales vice president for north and west India. Iyer will assume office on 27 September and will report to SABTNL national ad sales president Kanta Advani.
While confirming the news, Advani says: “Sonali and I have worked together in Zee TV. She will fill the void created by the departure of Sandeep Singh (designated as vice president) earlier this year. Now, we have three people in the western region, four to cover north India and one in south India.” Advani also offers that she will soon have a full fledged sales team in east India.
Iyer is a commerce graduate and has obtained her masters degree in business administration. She has a decade of experience which includes stints in Zee TV (five years) and Prime Time (five years). In Zee, she was part of the Zee Cinema team in addition to handling sales responsibilities of the flagship channel.
Also read:
“Humour is the central theme and the backbone of our programming thrust” – SABTNL national ad sales president Kanta Advani
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
